Main Article Content
Administration of probiotic strains for the prevention of antibiotic-associated diarrhea (AAD) in adults and children at the moment is the standard regimen of both Ukrainian and European treatment protocols. Saccharomyces boulardii are yeast probiotics. Their basic difference from bacterial probiotics (Lactobacіllus, etc.) is a resistance to antibiotics. In this regard, Saccharomyces boulardii can be used in conjunction with antibiotics for the prevention of side effects from the digestive tract caused by antibiotic therapy (especially AAD). The choice in this situation of a bacterial probiotic is less successful, because antibiotics can inhibit the activity of introduced bacteria. Importantly, Saccharomyces boulardii are not able to transfer antibiotic resistance to pathogenic bacteria, while bacterial probiotics have such a potential. The results of the clinical studies show high efficacy and safety of Saccharomyces boulardii in the prevention and treatment of antibiotic-associated diarrhea in children. In Ukraine, this probiotic is presented by Enterol®.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.
[Pediatricians of Ukraine - for rational antimicrobial therapy]. Zdorov'ya Ukrayiny`. 2010 Apr;19-20. Russian
Zaharenko SM. [Modern approaches to the prevention of antibiotic-associated suppression of the microflora of the gastrointestinal tract]. Lechashhij vrach. 2010;(11):68–73. Russian
[Innovative approaches to correction of microbiome in pediatric practice]. Zdorov'ya Ukrayiny`. 2016 Jun;4–6. Russian
[Rehabilitation of children with chronic diseases: problems and perspectives]. Ukr. med. chasopy`s. 2015;(110):32–35. Russian
Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, Vorisek V, Kopacova, M. [Small intestinal bacterial overgrowth syndrome]. World Journal of Gastroenterology. 2010;16(24):2978–2990. English
Belousova OJu. [Differentiated approach to the administration of probiotics for the correction of gastrointestinal disorders in infants] Association of Pediatric Gastroenterologists and Nutritionists of Ukraine. 2015. http://www.gastrokids.com.ua Russian
Chernikov VV, Surkov AN. [Antibiotic-associated diarrhea in children: the principles of prevention and treatment]. Voprosy sovremennoj pediatrii. 2012;11(2):48–55. Russian
Shul'pekova JuO. [Diarrhea associated with antibiotics intake, and probiotics for its prevention and treatment]. Russkij medicinskij zhurnal. 2010;(2):82-85. Russian
Zakordonec LV, Kramarev SA, Beregovaja TV, Tolstanova AN, Dovbinchuk TV. [Antibiotic-associated diarrhea: mechanisms of development and the possibility of correction]. Zdorov'e rebenka. 2013;(7):69–73. Russian
Surkov AN. [Modern technologies of treatment and prophylaxis of antibiotic-associated diarrhea in children]. Voprosy sovremennoj pediatrii. 2011;10(5):146–151. Russian
Antibiotic resistance in pediatric practice: the problem and its solution // Zdorov'ya Ukrayiny`. 2016 Jun;15–16. Russian
Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. [Probiotics for the prevention of pediatric antibiotic-associated diarrhea]. Cochrane Database Syst Rev. 2011 Nov 9;(11):CD004827. English
Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, Krabshuis J, Lemair T, Kaufmann P, de Paula JA, Fedorak R, Shanahan F, Sanders ME, Szajewska H, Ramakrishna BS, Karakan T, Kim N; World Gastroenterology Organization. [World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011]. J Clin Gastroenterol. 2012 Jul;46(6):468-81. English
Videlock EJ. [Meta-analysis: probiotics in antibiotic-associated diarrhea] Aliment Pharmacol Ther. 2012 Jun;35(12):1355-69. English
Pattani R, Palda VA, Hwang SW, Shah PS. [Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis]. Open Med. 2013 May 28;7(2):e56-67. English
Micklefield G. [Saccharomyces boulardii in the treatment and prevention of antibiotic-associated diarrhea]. MMW Fortschr Med. 2014 Apr 17;156 Suppl 1:18-22. German
McFarland LV. [Systematic review and meta-analysis of Saccharomyces boulardii in adult patients]. World J Gastroenterol. 2010 May 14;16(18):2202-22. English
Shan LS, Hou P, Wang ZJ, Liu FR, Chen N, Shu LH, Zhang H, Han XH, Han XX, Cai XX, Shang YX, Vandenplas Y. [Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections]. Benef Microbes. 2013 Dec 1;4(4):329-34. English
Floch MH, Walker WA, Sanders ME, Nieuwdorp M, Kim AS, Brenner DA, Qamar AA, Miloh TA, Guarino A, Guslandi M, Dieleman LA, Ringel Y, Quigley EM, Brandt LJ. [Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion]. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S69-73. English
Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ; European Helicobacter Study Group. [Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report]. Gut. 2012 May;61(5):646-64. English
Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, Vandenplas Y, Weizman Z; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. [Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics]. J Pediatr Gastroenterol Nutr. 2014 Apr;58(4):531-9. English